Skip to main content
. 2018 Jan 23;9(1):e02284-17. doi: 10.1128/mBio.02284-17

FIG 4 .

FIG 4 

Anti-HA stalk antibody titers observed based on clinical outcome categories compared to HAI and NAI titers. Mean prechallenge hemagglutinin inhibition (HAI) titer, neuraminidase inhibition (NAI) titer, and anti-HA stalk titer in those who experienced MMID (defined as experiencing symptoms and detectable shedding) versus those who did not. Black bars represent 95% confidence intervals. Statistically significant P values are indicated with an asterisk.